Status:
RECRUITING
The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )
Lead Sponsor:
University of Electronic Science and Technology of China
Conditions:
Healthy Adult Male
Eligibility:
MALE
18-35 years
Phase:
EARLY_PHASE1
Brief Summary
The main aim of the present study is to investigate whether orally (lingual spray) administered oxytocin influences human top-down attention via oxytocin receptors and whether its effects are dose- an...
Detailed Description
In a placebo-controlled double-blind between-subject design experiment, investigators plan to investigate whether oral (lingual spray) oxytocin influences human top-down attention via the oxytocin rec...
Eligibility Criteria
Inclusion
- Healthy male subjects without past or current psychiatric or neurological disorders
Exclusion
- History of or current neurological/psychiatric disorders;
- Use of psychotropic medications (including nicotine)
- Visual impairments
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT07140237
Start Date
September 1 2025
End Date
December 30 2025
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Life science and Technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China